Skip to main content
Jianhua Luo, MD, Pathology, Pittsburgh, PA

JianhuaLuoMD

Pathology Pittsburgh, PA

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Pathology; UPMC endowed chair of molecular carcinogenesis; Director, High Throughput Genome Center, University of Pittsburgh School of Medicine

Dr. Luo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Luo's full profile

Already have an account?

  • Office

    200 Lothrop Street
    University of Pittsburgh School of Medicine
    Pittsburgh, PA 15213
    Phone+1 412-648-8791
    Fax+1 412-648-5990

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1994 - 1998
  • University of Maryland at Baltimore
    University of Maryland at BaltimorePh.D., Pharmacology, Phi Kappa Phi, 1985 - 1991
  • Guangzhou Medical College
    Guangzhou Medical CollegeClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1997 - 2026
  • PA State Medical License
    PA State Medical License 1998 - 2024
  • American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

  • Honorable Guest 3rd International Pathology Conference, 2014
  • Top Doctors in America CNN, NY Times, HealthTap, 2012
  • American Top Pathologists American Consumer Research Council, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Therapeutic targeting at genome mutations of liver cancer by insertion of HSV1 thymidine kinase through Cas9-mediated editing  
    2. Muhamuda Kader, Wei Sun, Bao-Guo Ren, Yan-Ping Yu, Junyan Tao, Lesley M. Foley, Silvia Liu, Satdarshan P. Monga and Jian-Hua Luo, Hepatology
  • Novel Fusion Transcripts Associate with Progressive Prostate Cancer  
    Yan P. Yu, Ying Ding, Zhanghui Chen, Silvia Liu, Amantha Michalopoulos, Rui Chen, Zulfiqar G. Gulzar, Bing Yang, Kathleen Cieply, Alyssa Luvison, Bao-Guo Ren, James D...., American Journal of Pathology, 1/1/2014
  • Whole Genome Single Nucleotide Polymorphism Array Analysis is Complementary to Classical Cytogenetic Analysis in the Evaluation of Lymphoid Proliferations  
    Sarah E. Gibson, Jianhua Luo, Malini Sathanoori, Jun Liao, Urvashi Surti, George K. Michalopoulos and Steven H. Swerdlow, American Journal of Clinical Pathology, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Whole Genome Methylation Sequencing Reveals Distinct Impact of Differential Methylations on Gene Transcription in Prostate Cancer
    Jianhua Luo, Yan P. Yu, Ying Ding, George C. Tseng, Amantha Michalopoulos, Joel B. Nelson, FASEB J, 4/29/2014
  • High Fidelity Copy Number Analysis of Formalin-fixed and Paraffin-embedded Tissues Using Affymetrix CytoScan HD Chip
    Jian-Hua Luo, Amantha Michalopoulos, Ying Ding, Yan P, Proceeding of American Association for Cancer Research, 1/1/2014
  • Regulation of Liver Growth by Glypican 3, CD81, Hedgehog, and Hhex
    Vishakha Bhave, Wendy Mars, Shashikiran Donthamsetty, Jianhua Luo, William Bowen, and George Michalopoulos, FASEB J, 4/9/2013
  • Join now to see all

Lectures

  • Prostate Cancer Genome 
    Department of Pathology, University of Pittsburgh School of Medicine - 5/21/2014
  • Epigenome and Genome Markers of Prostate Cancer 
    San Antonio, TX - 4/14/2014
  • Genomic Markers of Prostate Cancer 
    Xi'An, China - 5/24/2013
  • Join now to see all

Other

Press Mentions

  • Targeted Transcriptome Analysis Uncovers Previously Unknown Isoform Reprograming in Colon Cancer
    Targeted Transcriptome Analysis Uncovers Previously Unknown Isoform Reprograming in Colon CancerAugust 13th, 2020
  • Clipping Cancer with CRISPR
    Clipping Cancer with CRISPRJanuary 12th, 2018